Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain (Q31561882)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

0 references

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

O'Shea E

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Esteban B

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Camarero J

3

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Green AR

4

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Colado MI

5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

65-74

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Carrier-dependent and Ca(2 )-dependent 5-HT and dopamine release induced by ( )-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and ( )-fenfluramine.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its congeners

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy).

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Lack of serotonin neurotoxicity after intraraphe microinjection of ( )-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Neurotoxicity of MDMA: neurochemical effects

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration.

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(00)00106-4

7 January 2021

Identifiers

10.1016/S0028-3908(00)00106-4

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31561882&oldid=1613068768"